233 related articles for article (PubMed ID: 28291401)
21. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
Lee AY; Golden DW; Bazan JG; Kopec M; Pelizzari CA; Aggarwal S; Chang DT; Liauw SL
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):306-312. PubMed ID: 28068238
[TBL] [Abstract][Full Text] [Related]
22. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
[TBL] [Abstract][Full Text] [Related]
23. Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients.
De Bari B; Lestrade L; Franzetti-Pellanda A; Jumeau R; Biggiogero M; Kountouri M; Matzinger O; Miralbell R; Bourhis J; Ozsahin M; Zilli T
J Cancer Res Clin Oncol; 2018 Apr; 144(4):781-789. PubMed ID: 29441419
[TBL] [Abstract][Full Text] [Related]
24. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Cassoni P; Arena V; Bustreo S; Faletti R; Rondi N; Morino M; Ricardi U
Med Oncol; 2016 Jul; 33(7):72. PubMed ID: 27277756
[TBL] [Abstract][Full Text] [Related]
25. Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma.
Julie DA; Oh JH; Apte AP; Deasy JO; Tom A; Wu AJ; Goodman KA
Acta Oncol; 2016; 55(2):208-16. PubMed ID: 25984929
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
Milano MT; Jani AB; Farrey KJ; Rash C; Heimann R; Chmura SJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):354-61. PubMed ID: 16168830
[TBL] [Abstract][Full Text] [Related]
27. Early dose-dependent cortical thinning of the femoral neck in anal cancer patients treated with pelvic radiation therapy.
Okoukoni C; Randolph DM; McTyre ER; Kwok A; Weaver AA; Blackstock AW; Munley MT; Willey JS
Bone; 2017 Jan; 94():84-89. PubMed ID: 27780791
[TBL] [Abstract][Full Text] [Related]
28. Pelvic insufficiency fractures following carbon-ion radiotherapy for uterine carcinomas.
Miyasaka Y; Okonogi N; Fukahori M; Furuichi W; Wakatsuki M; Kato S; Ohno T; Nakano T; Tsuji H
Radiother Oncol; 2021 Mar; 156():56-61. PubMed ID: 33278405
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.
Dasgupta T; Rothenstein D; Chou JF; Zhang Z; Wright JL; Saltz LB; Temple LK; Paty PB; Weiser MR; Guillem JG; Nash GM; Goodman KA
Radiother Oncol; 2013 May; 107(2):189-94. PubMed ID: 23692961
[TBL] [Abstract][Full Text] [Related]
30. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT.
Clivio A; Fogliata A; Franzetti-Pellanda A; Nicolini G; Vanetti E; Wyttenbach R; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):118-24. PubMed ID: 19181409
[TBL] [Abstract][Full Text] [Related]
31. Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG).
Tokumaru S; Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Yamauchi C; Suzuki O; Sakurai H; Teshima T; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N; Kudo S
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e195-200. PubMed ID: 22583605
[TBL] [Abstract][Full Text] [Related]
32. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
Salcedo MP; Sood AK; Jhingran A; Eifel PJ; Klopp AH; Iyer RB; Fellman BM; Jimenez C; Schmeler KM
Cancer; 2020 Jun; 126(11):2607-2613. PubMed ID: 32125711
[TBL] [Abstract][Full Text] [Related]
33. Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.
Arians N; Häfner M; Krisam J; Lang K; Wark A; Koerber SA; Hommertgen A; Debus J
BMC Cancer; 2020 Jan; 20(1):52. PubMed ID: 31964381
[TBL] [Abstract][Full Text] [Related]
34. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
White EC; Murphy JD; Chang DT; Koong AC
Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric parameters predictive of acute gastrointestinal toxicity in patients with anal carcinoma treated with concurrent chemotherapy and intensity-modulated radiation therapy.
DeFoe SG; Kabolizadeh P; Heron DE; Beriwal S
Oncology; 2013; 85(1):1-7. PubMed ID: 23736101
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity Assessment.
De Francesco I; Thomas K; Wedlake L; Tait D
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):604-10. PubMed ID: 27156162
[TBL] [Abstract][Full Text] [Related]
38. A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer.
Joseph KJ; Syme A; Small C; Warkentin H; Quon H; Ghosh S; Field C; Pervez N; Tankel K; Patel S; Usmani N; Severin D; Nijjar T; Fallone G; Pedersen J
Radiother Oncol; 2010 Jan; 94(1):60-6. PubMed ID: 19896229
[TBL] [Abstract][Full Text] [Related]
39. Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging.
Blomlie V; Rofstad EK; Talle K; Sundfør K; Winderen M; Lien HH
AJR Am J Roentgenol; 1996 Nov; 167(5):1205-10. PubMed ID: 8911181
[TBL] [Abstract][Full Text] [Related]
40. Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures.
Ikushima H; Osaki K; Furutani S; Yamashita K; Kishida Y; Kudoh T; Nishitani H
Gynecol Oncol; 2006 Dec; 103(3):1100-4. PubMed ID: 16919711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
